NBER WORKING PAPER SERIES

TECHNOLOGICAL PROGRESS AND HEALTH CONVERGENCE:
THE CASE OF PENICILLIN IN POST-WAR ITALY
Marcella Alsan
Vincenzo Atella
Jay Bhattacharya
Valentina Conti
Iv√°n Mej√≠a-Guevara
Grant Miller
Working Paper 25541
http://www.nber.org/papers/w25541

NATIONAL BUREAU OF ECONOMIC RESEARCH
1050 Massachusetts Avenue
Cambridge, MA 02138
February 2019

We would like to thank Giovanni Vecchi for useful discussion and comments during the early
stage of this research project. Alsan gratefully acknowledges support from the Eunice Kennedy
Shriver National Institute of Child Health and Human Development (NICHD) 5K01-HD084709.
Bhattacharya thanks the National Institute on Aging (NIA) for support for this work through the
Stanford Center for Demography and Economics of Health and Aging (5P30AG017253). Lena
Schoemaker, Afia Khan, Anlu Xing and Morgan Foy provided excellent research assistance. The
views expressed herein are those of the authors and do not necessarily reflect the views of the
National Bureau of Economic Research.
NBER working papers are circulated for discussion and comment purposes. They have not been
peer-reviewed or been subject to the review by the NBER Board of Directors that accompanies
official NBER publications.
¬© 2019 by Marcella Alsan, Vincenzo Atella, Jay Bhattacharya, Valentina Conti, Iv√°n Mej√≠aGuevara, and Grant Miller. All rights reserved. Short sections of text, not to exceed two
paragraphs, may be quoted without explicit permission provided that full credit, including ¬©
notice, is given to the source.

Technological Progress and Health Convergence: The Case of Penicillin in Post-War Italy
Marcella Alsan, Vincenzo Atella, Jay Bhattacharya, Valentina Conti, Iv√°n Mej√≠a-Guevara,
and Grant Miller
NBER Working Paper No. 25541
February 2019
JEL No. I10,J10,N00
ABSTRACT
Throughout history, technological progress has transformed population health, but the
distributional effects of these gains are unclear. New substitutes for older, more expensive health
technologies can produce convergence in population health outcomes, but may also be prone to
‚Äúelite capture‚Äù leading to divergence. This paper studies the case of penicillin using detailed
mortality statistics and exploiting its sharply-timed introduction in Italy after World War II. We
find penicillin reduced both the mean and standard deviation of infectious diseases mortality,
leading to substantial convergence across disparate regions of Italy. Our results do not appear to
be confounded by competing risks or mortality patterns associated with World War II.

Marcella Alsan
Stanford Medical School
Center for Health Policy/PCOR
117 Encina Commons, Room 218
Stanford, CA 94304
and NBER
malsan@stanford.edu

Valentina Conti
Food and Agriculture Organization of
the United Nations
Viale delle Terme di Caracalla
Rome 00153
Italy
valentinaconti23@yahoo.it

Vincenzo Atella
University of Rome Tor Vergata
atella@uniroma2.it

Iv√°n Mej√≠a-Guevara
Center for Population Health Sciences
Stanford University
Stanford, CA 94305
imejia@stanford.edu

Jay Bhattacharya
117 Encina Commons
CHP/PCOR
Stanford University
Stanford, CA 94305-6019
and NBER
jay@stanford.edu

Grant Miller
CHP/PCOR
Stanford University
117 Encina Commons
Stanford, CA 94305-6019
and NBER
ngmiller@stanford.edu

I

Introduction

Technological progress in medicine has been described as a leading explanation for the increase in post-World War II era (Davis 1956; Preston 1975; Easterlin 1999; Mokyr 2002;
Acemoglu and Johnson 2007) and is often put forth as a solution to health challenges in
developing countries. Yet technological progress can also have unintended consequences for
the distribution of disease. If only elites can afford a health technology, or if a technology is
a private good that might substitute for public good provision, such innovation could widen
health disparities, at least initially (Mosca 1939; Olson 1965; Kremer and Willis 2016; Ashraf
et al. 2016). Alternatively, ‚Äúbreakthrough‚Äù health technologies that are less expensive may
supplant older, more expensive ones may encourage population health convergence.
In this paper, we analyze the effects of the introduction of penicillin, arguably one of
the most important medical technologies of the twentieth century (Tomes 1990, 1998). Discovered to kill Staphylococcus bacteria by Alexander Fleming in 1928 ‚Äì and successfully
isolated and produced by Howard Florey, Ernst Chain, and Norman Heatley in 1939 ‚Äì
this new ‚Äúmiracle drug‚Äù quickly became the first-line treatment for pneumonia, diphtheria,
syphilis, gonorrhea, scarlet fever, and other infectious diseases (Dowling 1977; Levy 1992).1
Penicillin‚Äôs achievements were preceded by those of sulfa agents, the first chemotherapy developed to fight infection and the subject of scholarship by Jayachandran, Lleras-Muney
and Smith (2010), who find the introduction of sulfa drugs led to impressive reductions in
maternal mortality and pneumonia deaths in the historical United States.2
We build off the Jayachandran et al. (2010) study in two ways: first, by exploring the
role penicillin had on average mortality in Italy following its introduction by the United
1

The Lancet published a high-profile article in 1943 entitled ‚ÄúGeneral and Local Administration of Penicillin,‚Äù describing the effectiveness of penicillin in treating wounded soldiers in North Africa (Florey and
Florey 1943). Some scholars estimate that penicillin saved at least 300,000 lives during the Second World
War (Dowling 1977; Levy 1992; Ratcliff 1945).
2
Conybeare (1948), Loudon (1988), and Mackenbach and Looman (1998) also provide suggestive evidence
on the importance of antibiotics. By contrast, some studies suggest that penicillin did not have the dramatic
effect commonly attributed to it (Hemminki and Paakkulainen (1976) studying Finland and Sweden, for
example).

1

Nations in the aftermath of World War II, and second, and more generally, by documenting
the effects of the technology on the distribution of mortality.3 Some scholars suggest that the
distribution of new technologies, even inexpensive ones, often benefit the elite first (Brenzel
and Claquin 1994). Others suggest that more portable technologies which do not require
large scale infrastructure investments are less prone to elite capture and have considerable
potential to improve population health (Acemoglu and Robinson 2008; Mosca 1939; Olson
1965). For penicillin, this could be particularly true given that political decision-making
often targeted expensive water and sanitation infrastructure ‚Äì which can greatly reduce the
spread of infectious diseases ‚Äì towards more elite neighborhoods and communities (Bigatti
2014; Massarutto 2011; Picci 2002; Troesken 2004). Finally, technological progress may
be ‚Äúnecessary‚Äù but not ‚Äúsufficient‚Äù for health convergence ‚Äì institutions may be critical to
ensure benefits are distributed to those most in need.
To study the distributional consequences of the introduction of penicillin, we assemble a
dataset of Italian vital records spanning much of the twentieth century (Atella, Francisci and
Vecchi, 2017). We use these data to estimate the contribution of penicillin to infectious disease mortality decline in Italy during the twentieth century. Focusing on the years between
1924 and 1955, we first establish its average effect on mortality by interacting the sharp timing of penicillin introduction with causes of death sensitive to penicillin, controlling for timeand region-level effects as well as regional linear time trends. We then estimate penicillin‚Äôs
effect on the distribution of mortality in four ways: first, by analyzing changes in the age
distribution of deaths over time, using Kolmogorov-Smirnov (KS) tests to detect significant
differences in these distributions year-by-year; second, using our econometric approach akin
to our framework for studying mean reductions in mortality rates, but testing for differential
declines by initial level of infectious disease death rates; third, testing for Œ≤-convergence,
following the literature on macroeconomic growth and economic convergence (Barro and
Sala-i-Martin 1992); and, fourth, testing for œÉ-convergence by estimating the relationship
3
Sulfa drugs are distinct from beta-lactam antibiotics, of which penicillin is the first developed (Mandell,
Douglas and Bennett 2010).

2

between penicillin introduction and changes in the standard deviation of regional mortality
rates (Janssen et al. 2016).
We find sharply-timed reductions in penicillin-sensitive mortality rates across Italy that
closely coincide with the introduction of penicillin in 1947. There are no trend differences
between penicillin-sensitive and penicillin-insensitive diseases prior to 1947, and the subsequent decline of about 0.3 deaths per thousand annually represents a 66% reduction relative
to the average rate of penicillin-sensitive deaths in earlier years. Then, using all four estimation approaches, we find clear evidence of mortality rate convergence across regions of
Italy. Relative to years prior to 1947, the introduction of penicillin reduced the dispersion of penicillin-sensitive mortality rates across regions by 68%, explaining 40% of all-cause
convergence over this period.
We also consider two important threats to the internal validity of our analyses. The
first is competing risks. Because our estimation framework relies on comparisons between
penicillin-sensitive and penicillin-insensitive diseases, reductions in penicillin-sensitive deaths
could mechanically increase non-communicable disease (NCD) mortality as those benefitting
from penicillin live long enough to suffer and die from non-infectious causes. We show that
competing risks are not a threat in practice because the decline in penicillin sensitive death
rates is present when examining a simple change over time (i.e. not making comparisons with
NCDs). Furthermore, even when the sample time frame is limited to a very short window
following pencillin‚Äôs debut, thereby reducing the movement of infectious disease survivors
into deaths due to non-infectious causes, we still find statistically significant and medically
meaningful effects. The second issue is that penicillin was introduced shortly after the end of
World War II. Infectious disease mortality rates commonly surge during wartime (Erdem et
al. 2011; Zapor and Moran 2005), so their decline relative to non-infectious mortality rates
could partly reflect the end of conflict and regression to the mean. However, our results
are similar across areas with varying degrees of war-related destruction and are robust to
excluding years 1943‚Äì1945 (the years of most intense conflict in Italy) from our estimation.

3

The paper proceeds as follows. Section II provides historical background on public health
in Italy and the introduction of penicillin, and Section III describes the construction of the
dataset. Section IV focuses on the role of penicillin for mean reductions in mortality, and
examines penicillin‚Äôs contributions to population health convergence. Section V presents estimation results. Section VI considers competing risks and presents other robustness checks,
and Section VII concludes.
II

Background

II.A

Early Efforts to Combat Infectious Disease Mortality in Italy

At the time of unification in 1861, life expectancy at birth in Italy was approximately 29
years, and the crude death rate was about 35 per 1,000 people (Atella, Francisci and Vecchi,
2017). In 1887, Francesco Crispi‚Äôs government introduced the country‚Äôs first sanitary reforms
under the Crispi-Pagliani law.4 However, infectious disease deaths in Italy did not begin to
decline until the early twentieth century, which historians link to improvements in municipal
hygiene under provisions of the law governing water quality and sanitation in urban areas
(Giovannini 1996; Giuntini 1999; Pogliano 1984). During fascist rule (1920-1943), public
health initiatives targeted the so-called ‚Äútriple endemic diseases:‚Äù malaria, syphilis, and
tuberculosis.5
Italy‚Äôs nascent healthcare system and reforms often failed to reach its poorest members
(Giovannini 1996; Giuntini 1999; Pogliano 1984).6 Municipal authorities were responsible
for providing healthcare to the indigent, yet in practice private charitable organizations
4

The establishment of a health system is interpreted by historians as one of the most important achievements of Italian ‚Äúpolitical and moral life‚Äù at the beginning of the new Kingdom [Croce (1928), cited in
Cosmacini (2005), p. 345].
5
The most important provisions focused on malaria were issued between 1923 and 1934 through a series
of laws designed to arrive at a thorough land reclamation operation (bonifica integrale). The Consolidation
Act on the reclamation of marshlands was approved with Royal Decree no. 3256 of 30 December 1923. Law
no. 3134 of 24 December 1928, called the ‚ÄúMussolini Law,‚Äù granted financial resources to land reclamation
and provided for integration regarding the supply of drinking water and the construction of rural buildings,
hamlets, and roads.
6
The law‚Äôs principles of universalism became effective only in 1978, when the Italian National Health
Service System (SSN) was established.

4

provided these services (Opere Pie, or ‚ÄúPious Organizations‚Äù).7 A Royal Decree in 1884
established that private firms could invest in the water sector (Ermano and Massarutto
2012). Massarutto (2011) argues this decree and the ensuing privatization directed water
supply towards the wealthy in urban areas. As late as the 1950s, only 52% of private houses
in Italy received potable water (Doria 2010), and only 7% had all three utilities: potable
water, adequate sanitation, and electricity (Barra Bagnasco 1996).8
Mortality rates in Italy declined on average during the early- to mid-1900s (see Figure
1), though wide regional health disparities in infectious disease mortality were prevalent at
the beginning of this period (Figure 2, Panel A). Nationally, life expectancy at birth in Italy
rose to 40-45 years ‚Äì but varied by as much as 12 years across regions.9 These regional
disparities peaked in 1925-1930, remained high until WWII, and then declined sharply at
the end of the war. Understanding whether the introduction of penicillin contributed to the
compression of regional mortality rates is a central focus of this paper.
II.B

The Advent of Penicillin in Italy

The supply of penicillin in Italy began in 1947 (Luzzi 2004). In its early stage of distribution
(1945 and 1946) penicillin was available in Italy through international aid only, imported by
the UNRRA (United Nations Relief and Rehabilitation Administration) channel and limited
in quantity. At that time the black market was flourishing. Therefore, having enough money
and connections, people could reach for the drug (the initial distribution of penicillin in Italy
by the US Army started with the main intent of using it to treat the spreading of venereal
7

The ‚Äúnon-poor‚Äù generally used services provided by individual private-practice doctors (medici liberoesercenti ) who made home visits.
8
Until the end of WWII, national public spending for infrastructure was concentrated in the North. On
public investments in water, a Royal Decree issued in 1884 created a dualism in the management of water
services: water was public, but private companies could invest in the sector once awarded government licenses
(Ermano 2012). As a result, water was largely provided to wealthy families in urban areas (Massarutto
2011). Although many subsequent laws governing water management were issued between 1861 and 1950,
universalism in the water sector was not achieved until the late 1950s (Mantelli and Temporelli 2007).
Modern water infrastructure in poorer southern regions was completed only in the late 1980s (Mantelli and
Temporelli, 2007).
9
During the 1920s the regional variation in life expectancy at birth was almost as large as that estimated
for Indian states between 2011 and 2016 ‚Äì ranging from 61.5 years in Madhya Pradesh to 77 years in Kerala
(Ponnapalli et al., 2013).

5

diseases). To resolve this problem ENDIMEA (Ente Nazionale Distribuzione Medicinali
agli Alleati) was established, which began its work on October 1st, 1944. Since January
1st, 1945, each provincial health office began to communicate to the General Directorate
of Public Health (DGSP), within the Ministry of the Interior, estimates of the demand for
medicines for the quarter. The DGSP, based on the requests and the availability of drugs,
granted the drugs to the applicants, informing ENDIMEA to ship the product to the local
private wholesalers. Once the wholesaler collected the drugs, he was responsible for the
distribution of medicines to the Provincial Health Offices. The latter also had an obligation
to follow the drug during the journey from the wholesaler warehouse to the pharmacies or
hospitals, in order to prevent theft and illegal sales.10
Italian patients could receive the new drug free of charge if requested by their physicians.
Provincial Health Offices were held accountable for any shortages of medicines, and pharmacists received a high margin for the sale of antibiotics, which discouraged the emergence
of an underground market favoring the wealthy (Battini 1946; Luzzi 2004).
III

Data

III.A

Vital Statistics Data11

The Italian National Statistical Office (ISTAT) provides national vital statistics in annual
Health Statistics Yearbooks (Annuario di Statistiche Sanitarie) starting from 1887. Vital
statistics for years 1924-1955 were digitized at the region-year-cause of death level.12
Harmonizing Regions. ISTAT data provides death counts for Italy‚Äôs regions over time.
10

The Italian health authorities were responsible for any shortages of medicines. In the spring of 1945
the drug became available via physician prescription, but only in the City Public Health Offices (Ufficio
d‚ÄôIgiene). In 1947, the pharmaceutical company ‚ÄúSPA Milan‚Äù became the first private Italian company to
market antibiotics, selling Supercillin (in vials) and Prontocillin (tablets). A year later, the Anglo-American
monopoly over penicillin was broken by Domenico Marotta, then-director of the Istituto Superiore di Sanit,
who called Ernst Chain to lead the International Centre for Microbiological Chemistry in Rome.
11
For a complete description of the vital statistics, see Appendix A.
12
To the best of our knowledge, formal demographic analyses of the quality and completeness of Italy‚Äôs
historical mortality statistics have not been published. However, Italian vital statistics back to the nineteenth
century are included in the Human Mortality Database (HMD), and data quality is a central criterion for
HMD inclusion. http://www.mortality.org/. (Data documentation for Italy HMD available at: http:
//www.mortality.org/hmd/ITA/InputDB/ITAcom.pdf).

6

Due to changes in administrative regional borders over our period of investigation, we had
to aggregate some regions. From 1924 until the end of WWII, Italy was organized into
18 administrative regions with only minor changes across region borders. The only exception was the establishment of Valle dAosta in September 1945. For this reason, to obtain
a harmonized regional dataset from 1924 to 1954 we treat Piedmont and Valle dAosta as
a single region. Thus, our sample includes the following 18 regions: Piedmont and Valle
d‚ÄôAosta, Lombardy, Trentino Alto Adige, Veneto, Friuli Venezia Giulia, Liguria, Emilia Romagna, Tuscany, Umbria, Marche, Lazio, Abruzzi and Molise, Campania, Apulia, Basilicata,
Calabria, Sicily and Sardinia.13
Harmonizing Cause of Death. Officially, ISTAT assumed the responsibility of collecting
mortality data at individual level only in 1930, following Law no. 2238 issued in December
1929. Previously, the statistical office was within the Ministry of Agriculture, Industry and
Trade via Indagine sulle cause di morte. ISTAT collects this information using an official
reporting format (‚ÄúScheda di morte‚Äù) following international standards recommended by the
World Health Organization (WHO). These individual death certificates consist of two parts.
A general practitioner or coroner certifies the first part and ascribes cause. The ‚Äúinitial
cause‚Äù ‚Äì disease or trauma ‚Äì is recorded, which may have led to additional complications
but initiated a causal chain leading to death. Diagnostic codes are then assigned to each
death using WHO International Classification of Diseases (ICD) criteria. The second part
is completed by a municipal civil registrar and includes information about the demographic
and social characteristics of the deceased.
Causes of death reported in Italy‚Äôs vital records change over time. We therefore use
categories that can be consistently identified and tracked across all study years, effectively
adopting the classification used in 1956‚Äì1957 for all years of our analysis (1924‚Äì1955).14 We
13
For sake of completeness, in December 1963 the region of Molise was established by splitting the ‚ÄúAbruzzi
and Molise‚Äù into two distinct regions. This last change brought Italy to have the current administrative
structure based on 20 regions.
14
The 17 causes of death are the following: infective and parasitic diseases; tumors; allergic and endocrine
glands diseases; blood and hematopoietic diseases; psychic and personality disorders; nervous system diseases;
circulatory system diseases; respiratory system diseases; digestive system diseases; genitourinary system dis-

7

then classify each of these causes that can be consistently tracked over time according to
whether or not it can be treated with penicillin. Ultimately, this process yields 79 penicillininsensitive, 15 penicillin-sensitive, and 15 unclassified diseases.15 In our analysis of causespecific mortality we exclude unclassified deaths.
Constructing war related destruction indicator. We measure destruction related to World
War II using the number of military and civilian deaths directly related to war causes at the
regional level that occurred between 1940 and 1945 (ISTAT 1957).16
Constructing Rates. Finally, using death counts by region, year, and cause, we construct
mortality rates using data on regional populations in Italy over time. Specifically, to create
population denominators, we use regional population counts from Italy‚Äôs decennial population censuses provided by ISTAT. For inter-censual years, population estimates accounting
for births and deaths provides estimates of this population construction process using several
sources of population data (Vecchi, 2017; see Appendix A for more details).17
eases; complications of pregnancy; skin and tissue diseases; bones and locomotive organs diseases; congenital
malformations; early childhood particular diseases; senility and pathologic states; accidents, traumatisms,
and poisonings. The coding system adopted during years 1924‚Äì1955 has changed from the International
Analytical Classification (IAC) to the ISTAT Intermediate Classification (IIC) adopted in subsequent years.
Moreover, from 1958 onwards, there is a higher disaggregation of diseases with respect to years 1956‚Äì1957,
due to the inclusion of new death-related causes.
15
The list of ‚Äúpenicillin-sensitive‚Äù and ‚Äúpenicillin-insensitive‚Äù categories of death are reported in Appendix
B.
16
The war victims are quantified according to the region of actual death, delivering a space/time quantification of war conflicts. WWII severity indicator in Italy is provided by the official publication ‚ÄúMorti
e dispersi per cause belliche negli anni 1940‚Äì45‚Äù (The dead and the missing due to war causes between
1940‚Äì1945) (ISTAT, 1957). The intensity of war destruction was quantified based at the median. Regions
above-median conflict deaths are: Piedmont-Valle d‚ÄôAosta, Veneto, Friuli Venezia Giulia, Emilia Romagna,
Toscana, Umbria, Marche, Lazio. Lombardy, Trentino Alto Adige, Abruzzi and Molise, Campania, Puglia,
Basilicata, Campania, Sicilia, Sardegna. See Atella, Di Porto, and Kopinska (2017) for a detailed description
of the data used. WWII-related death rates were then computed by dividing death county by the average
regional population between 1940‚Äì1945.
17
Population estimates were interpolated into age bins of 0‚Äì25, 26‚Äì30, 31‚Äì35, 36‚Äì40, 41‚Äì45, 46‚Äì50, 51‚Äì
55, 56‚Äì60, 61‚Äì65, 66‚Äì70, 71‚Äì75, and 76+ by using known population data for years 1921‚Äì1927, 1931‚Äì1936,
1943‚Äì1950, 1953, 1957, and 1959‚Äì1961. To estimate missing population data, we broke the age bins into
separate individual age columns and assumed a uniform population distribution for each age within an age
bin. We interpolated missing age-specific population by taking the current year‚Äôs age-specific population
and adding the previous year‚Äôs age-specific mortality to get the previous year‚Äôs age-specific population. We
use the same methodology in the opposite direction by interpolating the age-specific population data of
the subsequent year by taking the current year‚Äôs age-specific population and subtracting the current year‚Äôs
population age-specific mortality. Afterwards, we re-aggregated the age columns into the original age bins
for the population controls of our study.

8

Our final sample contains region-year-cause of death observations for years 1924‚Äì1959.
Table 1 shows descriptive statistics on all-cause mortality for penicillin-sensitive and penicillininsensitive diseases before and after penicillin introduction.
III.B

Human Mortality Database (HMD) Data

We also use national-level data on age-specific deaths from the Human Mortality Database
(HMD) in two ways (HMD 2017).18 First, because the regional vital statistics do not contain
information about deaths by age, precluding age-adjustment, we control for age-specific
population counts.19 Second, we directly examine changes in the age distribution of deaths
over time as an alternative strategy for studying mortality convergence.
III.C

Graphical Analysis

Mortality Decline by Cause. As Figure 1 shows, Italy‚Äôs total mortality rate fell substantially
between 1924 and 1955. However, this decline varied dramatically by cause ‚Äì and in particular, by penicillin sensitivity. Panel A of Figure 2 shows that with the official introduction of
penicillin in 1947, the decline in regional mortality rates for penicillin-sensitive causes accelerated sharply. Moreover, the variance in regional death rates sensitive to penicillin became
markedly more compressed beginning in 1947, with substantial convergence occurring by
the mid-1950s. Panel B of Figure 2 demonstrates regional mortality rates for non-infectious
causes did not decline over the entire period ‚Äì nor did their variance.20
18

National-level HMD estimates are constructed by HMD investigators using vital statistics, population
censuses, and population estimates directly from ISTAT and from other researchers working on behalf of
ISTAT. Death counts in the Italian vital statistics are based on the de facto population (‚Äúpopolazione presente‚Äù) until 1980 and on the de jure population (‚Äúpopolazione residente‚Äù) afterwards. Therefore, mortality
rates before 1981 in the HMD are based on population estimates of the de facto population, calculated from
census counts to consider this change in the coverage of vital statistics (Glei 2015). Death counts from the
vital statistics are also adjusted both to include missing military deaths during World Wars I and II and
to spatially redistribute deaths by age and calendar year (Jdanov et al. 2008). For the period 1937‚Äì51,
intercensal survival methods are used to derive population estimates using pre- and post-war census counts
(Jdanov et al. 2008).
19
This data is also available online at:http://www.mortality.org/
20
More work is required to address concerns about the confounding role of World War II given that
infectious disease deaths often exceed direct casualties due to conflict (Erdem et al. 2011; Zapor and Moran
2005). We address this issue later in Section VI.B. Further, one might also argue that WWII has favored
internal migration flows from poorer to richer regions, thus contributing to higher differentials among regional
mortality rates. Atella, Deb and Kopinska (2019) show that the phenomenon of migration within Italian

9

Mortality Decline by Age. Figure 3 depicts the age distribution of period life table deaths
in Italy for years between 1924 and 1955. The figure reveals substantial reductions in infant
and child mortality over time (which are generally due to infectious causes, mostly penicillinsensitive (Vercelli et al. 2014)). As a result, deaths appear to become more concentrated at
older ages ‚Äì a pattern consistent with convergence, although the timing of this compression
is less readily evident (Section VI investigates this issue more closely).
Standard Deviation and Average Life Expectancy: Figure 4 shows both life expectancy
at birth and the standard deviation of age at death across regions (a common indicator
used in the literature to measure mortality convergence and lifespan inequality (Edwards
and Tuljapurkar 2005; Gillespie et al. 2014)) by year. Life expectancy at birth increases
from 51.5 in 1924 to 57.6 in 1939, declines abruptly during WWII until the 1943 Italian
armistice, recovers quickly to its pre-war level, and continues to increase in the post-war
years. The standard deviation of age at death declines little during the pre-war period (as
life expectancy at birth is rising), remains relatively constant during WWII, and then declines
precipitously beginning in the late 1940s (around the time that penicillin was introduced)
and throughout the post-war period. This rapid decline beginning in the latter 1940s is
suggestive of mortality convergence.
Standard Deviation by Cause: Figure 5 shows the standard deviation of regional death
rates separately for the all-cause mortality rates, penicillin-sensitive mortality rates, and
penicillin-insensitive mortality rates over time. Before WWII, the standard deviation trajectories of penicillin-sensitive and -insensitive mortality rates were similar. Both experience
disruptions during the war period, but after 1947 the standard deviation of penicillin-sensitive
mortality rates across regions converges, while the standard deviation of penicillin-insensitive
mortality rate slightly diverges.
regions began in earnest in 1951.

10

IV

Estimation

IV.A

Mortality Decline

Building on graphical evidence shown in Figures 2 and 4, our empirical strategy tests for
sharply-timed differential trend breaks in penicillin-sensitive mortality rates (relative to
penicillin-insensitive mortality rates) coincident with the introduction of penicillin in 1947.
Specifically, we estimate:

(1)

mict = Œ± + Œ≥i + Œ¥t + Œ∏c + Œ≤(Itpost ‚àó Sensitivec ) + Xit œï + Œ≥i ‚àó t + ict ,

for regions i, causes of death c, and years t. mict is a region-cause-year specific death rate
(specified both in level and natural log form). Itpost is a dummy variable equal to one for
observations in years 1947 or later, Sensitive is a dummy variable for whether or not cause
c is sensitive to penicillin, and X is a vector of covariates including interpolated population
estimates in discrete age categories. We include year, region, and disease fixed effects, and
our preferred specification also includes linear time trends interacted with region dummies.
Standard errors are clustered by region, and we report p-values corresponding to block
bootstrapped standard errors.21
We also assess the temporal dynamics of the introduction of penicillin by substituting a
vector of year dummy variables for , Itpost in Equation (1):

(2)

mict = Œ± + Œ≥i + Œ¥t + Œ∏c +

X

œÅj (Sensitivec ‚àó Itj ) + Xit œï + Œ≥i ‚àó t + ict ,

j

where Itj is a vector of j year dummy variables and all other variables are defined as before.
21

To assess the robustness of our results, we also estimate variants of specification (1), using both levels
and log specifications and including region-specific linear time trends.

11

IV.B

Mortality Convergence

To study mortality convergence at the national level, we first analyze changes in the distribution of age at death (Kannisto 2000; Fries 1980; Wilmoth and Horiuchi 1999). Specifically,
we use Kolmogorov-Smirnov (K-S) tests to formally assess if the timing of statistically significant changes in the distribution of age at death coincides with the introduction of penicillin
in 1947, comparing the distribution in each year between 1924-1954 with the last year in our
sample, 1955.22
Second, we test for mortality convergence associated with the introduction of penicillin
using an econometric framework similar to the one that we use for estimating mean reductions
in penicillin-sensitive mortality rates. Specifically, we re-estimate Equation (1), stratifying
by the pre-1947 level of both penicillin-sensitive mortality rates and overall regional mortality
rates.
Third, we test for Œ≤-convergence, or convergence in levels of mortality rates, following
the approach of Barro and Sala-i-Martin (1992) to study convergence in Gross Domestic
Product (GDP) per capita across countries. This approach assesses if regions with higher
pre-1947 penicillin-sensitive and -insensitive mortality rates converged towards regions with
lower mortality rates by sub-periods (before and after the introduction of penicillin, 19291946 and 1947-1955). Specifically, we estimate:

(3)

(mict ‚àí mict0 )
= Œ± + Œ≥i + Œ≤mict0 + it
(t ‚àí t0 )

where mict is the mortality rate in region i due to cause c in initial year t0 (t0 = 1924 for the
first sub-period, and t0 = 1947 for the second sub-period) and Œ≤ is the parameter of interest.
Finally, we test for œÉ-convergence, or convergence in the standard deviation of mortality
22

A two-sample Kolmogorov-Smirnov statistic is used to test whether two empirical one-dimensional
distribution functions (Fm (x), Gn (x)) differ from each other. The KS statistic is defined by the formula
Dmn = supx | Fm (x) ‚àí Gn (x) |. The null hypothesis that the q
two samples come fromqthe same distribution
is rejected, at the level of significance Œ±, when Dmn > c(Œ±)
1974).

12

m+n
mn ,

where c(Œ±) =

‚àí 12 ln( Œ±2 ) (Stephens,

rates, across regions of Italy by re-estimating Equation (1) using the standard deviation
of cause-specific mortality rates by region as the dependent variable (Janssen et al. 2016;
Young et al. 2008).
V

Results

V.A

Mortality Decline

Table 2 reports results obtained by estimating Equation (1). Conditioning on year, region,
and disease fixed effects as well as the regional age distribution, mortality rates among
diseases sensitive to penicillin relative to those insensitive fell by approximately 0.3 per
thousand (and is statistically distinguishable from zero, p < 0.01) with the introduction
of penicillin. Relative to the mean mortality rate among deaths due to these causes prior
to 1947 (0.469, see Table 1), this represents a reduction of 58%.23 Column 2 adds regionspecific linear time trends. In both cases, the estimate of Œ≤ is robust, with the mortality
rate decline associated with the introduction of penicillin remaining at about 0.3 per 1,000.
Columns 3 and 4 repeat this estimation for log mortality, showing robust reductions in
penicillin-sensitive mortality rates.
Figure 6 then examines the dynamic pattern of mortality decline associated with penicillin
introduction in Italy, showing estimates and 95% confidence intervals for each year-specific
œÅj in Equation (2). Prior to the introduction of penicillin, there is little evidence of preexisting declines in penicillin sensitive mortality rates (relative to insensitive ones). Yearspecific estimates drop with the introduction of penicillin in 1947 and become negative and
statistically different from zero by 1948 (and in all subsequent years) with the diffusion of
penicillin. By the end of our study period in 1955, these year-specific estimates approach a
decline of 2.8 per 1,000 deaths.
23

To estimate this effect we divide the post-1947 mean average reduction in the cause-specific mortality
(regression coefficient in the first column of Table 2: -0.272), by the mean mortality rate for penicillin-sensitive
causes in the baseline period, between 1924‚Äì1946.

13

V.B

Mortality Convergence

Figure 7 first shows year-by-year K-S p-values for tests of differences between each year‚Äôs
distribution of age at death against the distribution in 1955 (the last year in our sample).
These p-values remain constant at nearly 0 for all years prior to the introduction of antibiotics, indicating strongly significant differences from 1955 ‚Äì and then beginning in 1947,
these p-values rapidly rise to 1 (indicating no difference from 1955). This sharply-timed
compression in Italy‚Äôs age distribution of deaths is highly consistent with the introduction
of antibiotics leading to convergence in mortality rates.
Table 3 reports estimates obtained from Equation (1), stratified by level of penicillinsensitive mortality rates prior to 1947 (above and below the median). The first and second
columns show that after 1947, penicillin-sensitive mortality rates declined more in regions
with higher (above median) initial rates (by 0.29 per 1,000) than in those with lower (below
median) initial rates (0.26 per 1,000) ‚Äì and significantly so. Compared to the mean of the
pre-1947 penicillin-sensitive cause-specific mortality, these changes represent reductions of
61% and 55%, respectively.
Table 4 reports Œ≤-convergence estimates from Equation (3).

Comparing penicillin-

sensitive mortality rates before vs. after the introduction of penicillin, the estimate of Œ≤
is almost four times greater after penicillin introduction (-0.075 vs. -0.021). Alternatively,
for penicillin-insensitive mortality rates, the estimate is not statistically significant prior to
1947 ‚Äì and is positive and statistically different from 0 afterwards, suggesting divergence in
penicillin-insensitive mortality rates.
Finally, Table 5 (columns (1) and (2)) present estimates of sigma convergence by using the
standard deviation of deaths across regions and years for each of the two disease categories as
the dependent variable. We find that the standard deviation of penicillin-sensitive mortality
declines after penicillin is introduced (-0.113, p < 0.01) ‚Äì but not the standard deviation
of penicillin-insensitive mortality (-0.004). The results remain consistent after truncating
the sample in 1950 (row 2): the standard deviation of penicillin-sensitive mortality declines
14

significantly (-0.089, p < 0.01), but not for penicillin-insensitive mortality (-0.009).24
VI

Identification and Threats to Validity

In this section, we discuss two potential treats to our interpretation of the effects of the
introduction of antibiotics on infectious disease mortality. In Section VI.A, we consider the
problem of competing risks ‚Äì specifically, the survival benefit of antibiotics increased the
exposure of the population to death from non-infectious causes. In Section VI.B, we discuss
how the chaotic end to World War II may have affected infectious disease mortality in Italy
during our sample period.
VI.A

Competing Risks

In our context, the competing risks problem concerns a possible increase in non-communicable
disease (NCD) mortality resulting from fewer people dying from infectious disease mortality
as a result of the introduction of penicillin. This phenomenon can influence our estimates
given that we compare penicillin-sensitive vs. penicillin-insensitive death rates over time
(Tsiatis, 1975; Peterson, 1976; HonoreÃÄ and Lleras-Muney 2006). In this section we study the
influence that competing risks has on our estimation of the contribution of penicillin to the
mortality decline in Italy.25 We present a simple framework for defining the particular competing risk problem inherent in our main estimating equation, and describe an alternative
approach to bound the estimates.
Period 0: In any period, deaths can be divided into mortality from two etiologies E =
{I, N C} where I indicates infectious diseases and N C reflects non-communicable diseases.

(4)

D = I + NC

24

We use a truncated sample to test the potential treat of competing risks in the interpretation of the
effects of the introduction of penicillin on infectious disease mortality, including our interpretation of sigma
convergence ‚Äì see Section VI.A.
25
Technically, if competing risks is a problem, it amounts to a violation of the Stable Unit Treatment Value
Assumption (SUTVA), which is necessary for unbiased estimates in a difference-in-difference framework such
as ours.

15

note that deaths from etiology E can be expressed as the mortality rate from E multiplied
by the number of susceptible from that etiology at time t: E = ¬µe,t ‚àó S E,t . We assume that
mortality rate from non-communicable disease is exogenous to penicillin and, after period 0,
there are N 0 persons surviving in this closed population without births or migration.
Period 1: At the beginning of period 1, penicillin, p, is introduced which immediately treats
and cures those afflicted with infectious diseases, leading to a direct decline in mortality
associated with diseases of infectious etiology:

D1 = S I,1 ¬µI,1 (p) + S N C,1 ¬µN C

(5)

Period 2: By period 2, there are now indirect effects of penicillin, since those weaker
individuals that otherwise would have died from infectious disease are now alive (e.g. the
harvesting effect of infections has been reduced). These spared lives increase the size of the
susceptible non-communicable disease population:

S N C,2 = N 0 ‚àí S I,1 ¬µI,1 (p) ‚àí S N C,1 ¬µN C .

(6)

Recall that

‚àÇ¬µI,i
‚àÇp

< 0 by the pharmacology of penicillin and

‚àÇS N C,2
‚àÇp

> 0 by equation 6.

Hence the total effect of penicillin over time reflects both the direct effect on infectious deaths
and its indirect effect on non-communicable susceptibles.
Our difference-in-differences estimate compares the changes in infectious and non-communicable
diseases related deaths, before vs. after the introduction of penicillin:26

(7)







S I,2 ¬µI,2 (p) ‚àí S I,0 ¬µI,0 ‚àí S N C,2 (p)¬µN C ‚àí S N C,0 ¬µN C



Given that the first term is negative (by the direct effects of penicillin) and the second, in
26
Equation 7 is normalized by total population in our empirical framework. Note there is also a positive
effect on susceptibles for infectious diseases at the beginning of period 2, but we ignore that detail since
it is dwarfed by the first order effect of penicillin which is to reduce the mortality associated with many
communicable causes.

16

the absence of an overall secular decline in mortality, is positive (by the indirect effects of
penicillin), our estimates are biased away from the null.27 Yet in our setting, there may
be a very prominent secular decline in mortality for all causes ‚Äì which is why a differencein-differences framework is preferred. Thus, estimates from both the simple and double
differences are biased, the former by a secular decline and mis-attribution of penicillin to
secular patterns, and the latter by competing risks.
To gauge the relative importance of these two sources of bias, we zoom in on the period very soon after penicillin was introduced (i.e. Period 1), so that our difference-indifferences estimator is not influenced by competing risks (i.e. there is no indirect effects on
non-communicable disease):



 



S I,1 ¬µI,1 (p) ‚àí S I,0 ¬µI,0 ‚àí S N C,1 ¬µN C ‚àí S N C,0 ¬µN C . Shortly af-

ter penicillin is introduced, we are more likely to isolate the direct effect of penicillin on the
infectious disease mortality as the harvesting and death for more chronic, non-communicable
entities would not have not had time to occur. Specifically, we estimate the effect of penicillin on sensitive (i.e. infectious) and insensitive (i.e. non-communicable) causes in a pre
vs. post framework and using the full vs. a truncated time period.
These results are gathered in Table 5. For the truncated sample, ending in the year 1950
‚Äì three years following the introduction of penicillin into Italy ‚Äì the results demonstrate that
both sensitive and insensitive mortality decline (row (2) columns (3) and (4)) though the
effect is much larger for the former. The estimates point to an important secular decline
in mortality, independent of penicillin, hence the negative post coefficient in column (4).
The difference-in-differences estimate ((‚àí0.486) ‚àí (‚àí.0363)) is about ‚àí0.12, smaller than
the main estimates in Table 2 and a lower bound on penicillin‚Äôs effects.
Using the full sample, with an end year of 1955, the effect of penicillin introduction on
insensitive causes is more positive, reflecting the competing risk issue. Yet the magnitude
of this change is slight and statistically indistinguishable from the estimates using the 1950
cutoff. Moreover, the fact that the difference-in-differences point estimates are increasing
27

In the presence of a secular decline, the second term will be less negative than in the counterfactual of
absent an indirect effect of penicillin.

17

over time as per our event study is attributable to the first term in equation 7: the direct
effect of penicillin on infectious disease mortality (see row (3)). As discussed above, this
likely reflects the technology‚Äôs diffusion. When turning to sigma convergence, there is no
major concern for competing risks in any specification: convergence is limited to infectious
causes.
In summary, the framework and results presented in this subsection show that the competing risks problem in our context is small, given that a longer time window does not greatly
bias the second term in equation 7 in a positive direction. On the other hand, controlling for
a secular decline in mortality ‚Äì which is what differencing out of non-communicable causes
affords ‚Äì is important for obtaining less biased estimates.
VI.B

The End of World War II

Another potential concern with our results is the influence of the end of World War II on
infectious disease rates. Because infectious disease mortality rates commonly surge during
wartime (Erdem et al. 2011; Zapor and Moran 2005), their decline relative to non-infectious
mortality rates could partly reflect the end of conflict. Figure 2 (Panel A) provides at least
some prima facie evidence that this is not an important concern in our case ‚Äì mortality rates
sensitive to penicillin are declining until 1930, generally remain stable through 1945 (rather
than rising), and then resume their decline. However, we probe this issue further in two
ways.
First, we test for differential penicillin effects in areas with varying degrees of war-related
destruction. Specifically, we re-estimate Equation (1) separately for regions with aboveand below-median degrees of war intensity, measured using conflict-related mortality rates
between 1940 and 1945.28 Columns 3 and 4 of Table 3 report estimates separately for regions
with higher and lower intensity of exposure to WWII. In general, the penicillin effect is larger
in areas with lower war intensity (0.29 per 1,000) relative to those with higher war intensity
28

This data is available in ‚ÄúMorti e dispersi per cause belliche negli anni 1940‚Äì45‚Äù (ISTAT, 1957) and is also
online at https:lipari.istat.it/digibib/causedimorte/IST3413mortiedispersipercausebellicheanni1940 45+OCRottimizz.pdf.

18

(0.26 per 1,000), and this difference is statistically significant.29
Second, we simply exclude years 1943‚Äì1945 (the years of greatest conflict in Italy) from
our sample and again re-estimate Equation (1). Columns 5 and 6 of Table 3 show these
results ‚Äì the estimates are statistically equivalent to those that include these years.
VII

Conclusion

Although technological progress in health has produced dramatic gains in life expectancy
around the globe over the past century, it can also have unintended consequences for the distribution of disease. Health technologies that are inexpensive and substitute for older, more
expensive ones may lead to population health convergence, but they could also disproportionately benefit elites, widening health disparities. Notably, there has been little empirical
evidence to date on the consequences of major new health technologies for the distribution
of health in populations.
Studying the seminal case of penicillin and focusing on Italy using newly digitized vital
statistics over several decades, we find that the introduction of penicillin not only reduced average infectious disease mortality rates dramatically (by 58%), but it also led to a substantial
reduction in the variance of mortality rates across Italian regions. Specifically, the standard
deviation in the age of death fell by nearly eight years after the introduction of penicillin
‚Äì a decline of 27%. Our findings relate to the scholarship of researchers investigating postWorld War II health convergence across countries, such as Acemoglu and Johnson (2007)
and Deaton (2006), we find that the distribution of penicillin, at least in Italy, played an important role in such convergence and suggest an important role for point-of-care technologies
in reducing health inequalities.
29

We test for the significance of the difference between the coefficients obtained in the separate models by
pooling the samples used in both models, and specifying a triple interaction that includes an indicator for
high and low destruction. The coefficient for this interactions term was statistically significant (p-values <
0.01).

19

References
[1] Acemoglu, Daron, and Simon Johnson. 2007. ‚ÄúDisease and Development: The Effect of
Life Expectancy on Growth.‚Äù Journal of Political Economy 115: 925‚Äì985.
[2] Acemoglu, Daron, and James A. Robinson. 2008. ‚ÄúPersistence of Power, Elites, and
Institutions.‚Äù American Economic Review 98 (1): 267‚Äì93.
[3] Ashraf, Nava, Edward L. Glaeser, and Giacomo A. M. Ponzetto. 2016. ‚ÄúInfrastructure,
Incentives, and Institutions.‚Äù American Economic Review 106 (5): 77‚Äì82.
[4] Atella, Vincenzo, Partha Deb, and Joanna A. Kopinska. 2019. ‚ÄúHeterogeneity in longterm health outcomes of Migrants within Italy.‚Äù Journal of Health Economics 63: 19‚Äì33.
[5] Atella, Vincenzo, Edoardo Di Porto, and Joanna Kopinska. 2017. ‚ÄúStress, Famine and
the Fetal Programming: The Long Term Effect of WWII in Italy.‚Äù CEIS Research Paper
385.
[6] Atella, Vincenzo, Silvia Francisci, and Giovanni Vecchi. 2017. ‚ÄúHealth.‚Äù In Measuring
Wellbeing: A History of Italian Living Standards, edited by Giovanni Vecchi, Oxford
University Press.
[7] Barra Bagnasco, M. 1996. ‚ÄúHousing and Workshop Construction in the City.‚Äù In The
Western Greeks, 353‚Äì60, edited by G. Pugliese Carratelli. Milan.
[8] Battini, B. 1946. ‚ÄúServizio di distribuzione della penicillina, in ACISP, Notiziario
dell‚ÄôAmministrazione Sanitaria 1944‚Äì1945.‚Äù Fascicolo unico, Roma, 226‚Äì32.
[9] Barro, Robert J., and Xavier Sala-i-Martin. 1992. ‚ÄúConvergence.‚Äù The Journal of Political Economy 100 (2): 223‚Äì51.
[10] Bigatti, Giorgio. 2014. ‚ÄúDa bere per tutti. Servizi idrici e politiche dell‚Äôacqua in Italia
tra Otto e Novecento. Uno sguardo di sintesi.‚Äù TST n‚ó¶ 26: 110‚Äì27.
[11] Brenzel, Logan, and Pierre Claquin. 1994. ‚ÄúImmunization Programs and Their Costs.‚Äù
Social Science & Medicine 39 (4): 527‚Äì36. doi:10.1016/0277-9536(94)90095-7.
[12] Conybeare, John. 1948. ‚ÄúThe Effects on Mortality of Recent Advances in Treatment.‚Äù
Journal of the Institute of Actuaries 74: 57‚Äì81.
[13] Cosmacini, Giorgio, 2005. ‚ÄúStoria della medicina e della sanitaÃÄ in Italia.‚Äù Roma: Laterza.
[14] Croce, Benedetto. 1928. ‚ÄúStoria d‚ÄôItalia dal 1871 al 1915.‚Äù Bari: Laterza.
[15] Davis, Kingsley. 1956. ‚ÄúThe Amazing Decline of Mortality in Underdeveloped Areas.‚Äù
American Economic Review 46 (2): 305‚Äì18.
[16] Deaton, A. 2006. The Great Escape: A Review Essay on Fogel‚Äôs The Escape from
Hunger and Premature Death 1700-2100. Journal of Economic Literature 44 (1): 106114.
20

[17] Doria, Miguel de FrancÃßa. 2010. ‚ÄúFactors Influencing Public Perception of Drinking Water
Quality.‚Äù Water policy 12 (1): 1‚Äì19.
[18] Dowling, Harry. 1977. Fighting Infection: Conquests of the Twentieth Century. Cambridge: Harvard University Press.
[19] Easterlin, Richard. 1999. ‚ÄúHow Beneficent Is the Market? A Look at the Modern History
of Mortality.‚Äù European Review of Economic History 3 (3): 257‚Äì94.
[20] Edwards, Ryan D., and Shripad Tuljapurkar. 2005. ‚ÄúInequality in Life Spans and a New
Perspective on Mortality Convergence across Industrialized Countries.‚Äù Population and
Development Review 31 (4): 645‚Äì674.
[21] Erdem, Hakan, Ahmet Tetik, Ozgur Arun, Bulent Ahmet Besirbellioglu, Omer Coskun,
and Can Polat Eyigun. 2011. ‚ÄúWar and Infection in the Pre-Antibiotic Era: The Third
Ottoman Army in 1915.‚Äù Scandinavian Journal of Infectious Diseases 43 (9): 690‚Äì95.
doi:10.3109/00365548.2011.577801.
[22] Ermano, Paolo. 2012. ‚ÄúGli investimenti nel servizio idrico in Italia: un‚Äôanalisi storica.‚Äù
DIES Working Paper 3/2012.
[23] Ermano, Paolo, and Antonio Massarutto. 2012. ‚ÄúL‚Äôacqua come bene economico: profili
allocativi e distributivi.‚Äù Diritto Pubblico Comparato ed Europeo, 1-2012.
[24] Florey, M. E., and Howard W. Florey. 1943. ‚ÄúGeneral and Local Administration of
Penicillin.‚Äù Lancet 1 (387).
[25] Fries, James F. 1980. ‚ÄúAging, Natural Death, and the Compression of Morbidity.‚Äù New
England Journal of Medicine 303 (3): 130‚Äì5. doi:10.1056/NEJM198007173030304.
[26] Gillespie, Duncan O. S., Meredith V. Trotter, and Shripad D. Tuljapurkar. 2014. ‚ÄúDivergence in Age Patterns of Mortality Change Drives International Divergence in Lifespan
Inequality.‚Äù Demography 51 (3): 1003‚Äì17. doi 10.1007/s13524-014-0287-8.
[27] Giovannini, Carla. 1996. ‚ÄúRisanare la citta‚Äò. L‚Äôutopia igienista di fine Ottocento.‚Äù Angeli
ed., Milano.
[28] Giuntini, Andrea. 1999. ‚ÄúGli ingegneri sanitari e l‚Äôutopia igienista.‚Äù In Giuntini, A.,
Minesso, M., Gli ingegneri in Italia tra 800 e 900, Milano, Franco Angeli, 117‚Äì128.
[29] Glei, Dana. 2015. ‚ÄúAbout Mortality Data for Italy.‚Äù Retrieved from http://www.
mortality.org/hmd/ITA/InputDB/ITAcom.pdf (February 14, 2017)
[30] Golini A., Ciucci L., Caselli G. and Istat - Reparto studi sulla popolazione, 1983. Ricostruzione della popolazione residente per sesso, et e regione. Anni 1952-1972‚Äù. Universit degli Studi di Roma ‚ÄúLa Spienza‚Äù, Dipartimento di Scienze Demografiche, Fonti
e strumenti, n.1.

21

[31] Hemminki, Elina, and Anneli Paakkulainen. 1976. ‚ÄúThe Effect of Antibiotics on Mortality from Infectious Diseases in Sweden and Finland.‚Äù Am J Public Health. 66 (12):
1180‚Äì4.
[32] HonoreÃÅ, Bo E., and Adriana Lleras-Muney. 2006. ‚ÄúBounds in Competing Risks Models
and the War on Cancer.‚Äù Econometrica 74 (6): 1675‚Äì98.
[33] Human Mortality Database (HMD). University of California, Berkeley (USA), and Max
Planck Institute for Demographic Research (Germany). Available at www.mortality.org
or www.humanmortality.de (data downloaded on Jan 28th, 2017).
[34] ICD
(International
Classification
http://www.wolfbane.com/icd/icd6h.htm

of

Diseases),

1948.

[35] ISTAT (National Institute of Statistics) 1956, Annuario di Statistiche Sanitarie (Volume
II 1956).
[36] ISTAT (National Institute of Statistics) 1957a, Annuario di Statistiche Sanitarie (Volume III, 1957).
[37] ISTAT (National Institute of Statistics) 1957b. ‚ÄúMorti e dispersi per cause belliche negli
anni 1940‚Äì45.‚Äù Rome.
[38] ISTAT (National Institute of Statistics) 1958, Cause di morte 1888-1955, 1958, Roma.
[39] Janssen, Fanny, Anthe van den Hande, Joop de Beer, and Leo J. G. van Wissen. 2016.
‚ÄúSigma and Beta Convergence in Regional Mortality.‚Äù Demographic Research 35: 81‚Äì
116.
[40] Jayachandran, Seema, Adriana Lleras-Muney, and Kimberly V. Smith. 2010. ‚ÄúModern
Medicine and the Twentieth Century Decline in Mortality: Evidence on the Impact of
Sulfa Drugs.‚Äù American Economic Journal: Applied Economics 2 (2): 118‚Äì46.
[41] Jdanov, Dmitri A., Dana A. Glei, and Domantas Jasilionis. 2008. ‚ÄúA Modeling Approach
for Estimating Total Mortality for Italy during the First and Second World Wars.‚Äù
Center for the Economics and Demography of Aging (CEDA) Papers: Paper 20080001CL.
[42] Kannisto, VaÃàinoÃà. 2000. ‚ÄúMeasuring the Compression of Mortality.‚Äù Demographic Research 3. doi:10.4054/DemRes.2000.3.6.
[43] Kremer, Michael, and Jack Willis. 2016. ‚ÄúGuns, Latrines, and Land Reform: Private
Expectations and Public Policy.‚Äù NBER Working Paper 21915.
[44] Levy, Stuart B. 1992. The Antibiotic Paradox: How Miracle Drugs Are Destroying the
Miracle. New York: Plenum Press.
[45] Loudon, Irvine. 1988. ‚ÄúMaternal Mortality: 1800‚Äì1950. Some Regional and International Comparisons.‚Äù Social History of Medicine 1: 183‚Äì228.
22

[46] Luzzi Saverio. 2004. ‚ÄúSalute e sanitaÃÄ nell‚ÄôItalia Repubblicana.‚Äù Donzelli Editore, Roma.
[47] Mackenbach, Johan P., and Caspar W. Looman. 1988. ‚ÄúSecular Trends of Infectious
Disease Mortality in the Netherlands, 1911‚Äì1978: Quantitative Estimates of Changes
Coinciding with the Introduction of Antibiotics.‚Äù International Journal of Epidemiology
17 (3): 618‚Äì624.
[48] Mandell Gerald, John Douglas and Raphael Bennett, 2010 Principles and Practices of
Infectious Disease Routledge Press : Philadelphia, PA.
[49] Mantelli, Francesco, and Giorgio Temporelli. 2007. ‚ÄúL‚Äôacqua nella storia.‚Äù Milano,
Franco Angeli.
[50] Massarutto, Antonio. 2011. ‚ÄúPrivati dell‚Äôacqua.‚Äù Bologna, Il Mulino.
[51] Mokyr, Joel. 2002. ‚ÄúInnovation in an Historical Perspective: Tales of Technology and
Evolution.‚Äù In Technological Innovation and Economic Performance, edited by Benn
Steil, David G. Victor, and Richard R. Nelson, 23‚Äì46. Princeton: Princeton University
Press.
[52] Mosca, Gaetano. 1939. The Ruling Class. New York: McGraw-Hill.
[53] Olson, Mancur C. 1965. The Logic of Collective Action; Public Goods and the Theory
of Groups. Cambridge: Harvard University Press.
[54] Picci, Lucio. 2002. ‚ÄúLe opere pubbliche dall‚ÄôunitaÃÅ d‚ÄôItalia: l‚Äôinformazione statistica.‚Äù
Rivista di Politica Economica.
[55] Pogliano, Claudio. 1984. ‚ÄúScienza e stirpe: eugenica in Italia 1912-1939.‚Äù Passato e
Presente 5, Rivista di storia contemporanea: 61‚Äì97.
[56] Ponnapalli, Ramani, Krishna M. Ponnapalli, and A. Subbiah. 2013. ‚ÄúAging and the
Demographic Transition in India and Its States: A Comparative Perspective.‚Äù International Journal of Asian Social Science 3 (1): 171‚Äì193.
[57] Peterson, A. V. 1976. ‚ÄúBounds for a joint distribution function with fixed subdistribution functions: Application to competing risks.‚Äù Proceedings of the National
Academy of Sciences 73(1), 11-13.
[58] Preston, Samuel H. 1975. ‚ÄúThe Changing Relation between Mortality and Level of
Economic Development.‚Äù Population Studies 29 (2): 231‚Äì248.
[59] Ratcliff, J.D. 1945. ‚ÄúYellow Magic: The Story of Penicillin. Random House‚Äù.
[60] Stephens, M. A. 1974. ‚ÄúEDF Statistics for Goodness of Fit and Some Comparisons.‚Äù
Journal of the American Statistical Association 69 (347): 730‚Äì737. doi:10.2307/2286009.
[61] Tsiatis, A. 1975. ‚ÄúA nonidentifiability aspect of the problem of competing risks.‚Äù Proceedings of the National Academy of Sciences, 72(1), 20-22.
23

[62] Tomes, Nancy. 1990. ‚ÄúThe Private Side of Public Health: Sanitary Science, Domestic
Hygiene, and the Germ Theory, 1870‚Äì1900.‚Äù Bulletin of the History of Medicine LXIV:
509‚Äì539.
[63] Tomes, Nancy. 1998. The Gospel of Germs: Men, Women, and the Microbe in American
Life. Cambridge: Harvard University Press.
[64] Troesken, Werner. 2004. Water, Race, and Disease. Cambridge: MIT Press.
[65] Vecchi Giovanni. 2017. Measuring Wellbeing. A History of Italian Living Standards.
Oxford: Oxford University Press.
[66] Vercelli, Marina, Roberto Lillini, Alberto Quaglia, Rosanna T. Micale, Sebastiano La
Maestra, and Silvio De Flora. 2014. ‚ÄúAge-Related Mortality Trends in Italy from 1901
to 2008.‚Äù PLoS ONE 9 (12). doi:10.1371/journal.pone.0114027.
[67] Wilmoth, John R., and Shiro Horiuchi. 1999. ‚ÄúRectangularization Revisited: Variability
of Age at Death within Human Populations.‚Äù Demography 36 (4): 475‚Äì495. https:
//doi.org/10.2307/2648085.
[68] Young, Andrew T., Matthew J. Higgins, and Daniel Levy. 2008. Sigma Convergence
versus Beta Convergence: Evidence from U.S. County-Level Data. Journal of Money,
Credit and Banking 40 (5): 1083‚Äì1093.
[69] Zapor, Michael J., and Kimberly A. Moran. 2005. ‚ÄúInfectious Diseases during Wartime.‚Äù
Current Opinion in Internal Medicine 4 (6): 543‚Äì47.

24

Figure 1: All-cause mortality rates across all regions in Italy, 1924-1955. The unit is number
of deaths per 1,000 people. Source: ISTAT

25

Figure 2: Penicillin-sensitive (Panel A) and penicillin-insensitive (Panel B) disease mortality
rates by region in Italy, 1924-1955. The unit is number of deaths per 1,000 people. Source:
ISTAT

26

Figure 3: Period life-table distributions of age at death in Italy for selected years between
1924 and 1955. The unit is the logarithm of the probability density of deaths. Source:
Human Mortality Database (HMD)

27

Figure 4: Life expectancy at birth and standard deviation of age at death in Italy, 1924‚Äì
1955. The trajectories of the life expectancy at birth (left-hand side scale), and the standard
deviation of age at death (right-hand side scale)are based on the distributions of age at death
from Fig. 3.

28

Figure 5: Standard deviation (SD) of all-cause, penicillin-sensitive, and penicillin-insensitive
disease mortality in Italy, 1924‚Äì1955. The figure shows absolute levels of the SD by age
grouped in approximately 5-year bins. For the decade of 1940, we consider two age groups
using 1947 as a cut off to illustrate the effect of the introduction of penicillin in that year.

29

Figure 6: Penicillin-sensitive disease regression coefficients by year (log mortality), 1924‚Äì
1955. The figure shows regression coefficients for penicillin-sensitive diseases by year, pre1947 and post-1947. The outcome is log mortality per 1,000. Regression included year and
region fixed effects, disease fixed effects, region-disease specific trends, and an interpolated
population estimate for age bins 0‚Äì25, 26‚Äì30, 31‚Äì35, 36‚Äì40, 41‚Äì45, 46‚Äì50, 51‚Äì55, 56‚Äì60,
61‚Äì65, 66‚Äì70, 71‚Äì75, 76+. Standard errors are clustered by region.

30

Figure 7: Kolmogorov-Smirnov (KS) test of the equality of age at death mortality distributions in Italy, 1924‚Äì1958. The figure illustrates the significance level (p-value) of the KS test
for the equality of mortality distributions depicted in Fig. 3, using the distribution of 1955
as the baseline.

31

Table 1 Descriptive statistics comparing cause-specific mortality before and after 1947
Descriptive Statistics
1924‚Äì1946
VARIABLES
N
Mean
SD
Penicillin-Sensitive Cause-Specific Mortality (per
1,000)

3,726

0.469

0.652

Penicillin-InsensitiveCause-Specific Mortality (per
1,000)

11,093

0.237

0.510

N

Mean

SD

Penicillin-Sensitive Cause-Specific Mortality (per
1,000)

1,457

0.189

0.265

Penicillin-Insensitive Cause-Specific Mortality (per
1,000)

4,622

0.217

0.518

1947‚Äì1955
VARIABLES

Note: The table reports descriptive statistics on the penicillin-sensitive and -insensitive specific mortality
from 1924‚Äì1946 and 1947‚Äì1955. Cause-specific mortality is the number of deaths per 1,000 people.
Source: ISTAT.

32

Table 2 Baseline regressions of cause-specific mortality in Italy by regions, 1924‚Äì1955
Cause-Specific Mortality per
Log Cause-Specific Mortality
Outcome
1,000
per 1,000
(1)

(2)

(3)

(4)

-0.272***
(0.008)

-0.272***
(0.008)

-0.611***
(0.023)

-0.610***
(0.023)

Block Bootstrap SE
Block Bootstrap p-value

(0.008)
{0.002}

(0.008)
{0.002}

(0.022)
{0.002}

(0.023)
{0.002}

Observations
R-squared
Year FE
Region FE
Disease FE
Region Trends
No. Clusters

20,898
0.867
Yes
Yes
Yes
No
18

20,898
0.868
Yes
Yes
Yes
Yes
18

20,892
0.887
Yes
Yes
Yes
No
18

20,892
0.887
Yes
Yes
Yes
Yes
18

Sensitive*Post

Note: The table presents coefficient estimates for the regressions of cause-specific mortality per 1,000 on a
dummy variable for disease specific penicillin-sensitivity equal to 1 starting from 1947. In columns (1) and
(2) cause-specific mortality per 1,000 is in levels. In columns (3) and (4) cause-specific mortality is in logs.
All columns include year, region, disease fixed effects (FE), and interpolated population estimates for age
bins 0‚Äì25, 26‚Äì30, 31‚Äì35, 36‚Äì40, 41‚Äì45, 46‚Äì50, 51‚Äì55, 56‚Äì60, 61‚Äì65, 66‚Äì70, 71‚Äì75, 76+. Columns (2) and
(4) additionally include region-specific trends. Standard errors (SE) in parentheses are clustered by region.
Block bootstrap p-values are indicated in curly brackets

33

Table 3 Regression results by median of pre-1947 characteristics in Italy, 1924‚Äì1955
Sensitivity to WWII Mortality
Approach 1: Varying Degrees of
War-Related Destruction

Sample

Above the
Median of
All-Cause
Pre-1947
Mortality
(1)

Below the
Median of AllCause Pre1947 Mortality

Approach 2: Same as Columns
(1) and (2), but Excluding Years
Between 1943‚Äì1945
Above the
Median of
Below the Median
All-Cause
of All-Cause PrePre-1947
1947 Mortality
Mortality
(5)
(6)

(2)

Regions with
High Destruction
(3)

Regions with
Low
Destruction
(4)

-0.287***
(0.012)

-0.257***
(0.011)

-0.257***
(0.011)

-0.287***
(0.012)

-0.303***
(0.012)

-0.271***
(0.012)

Block Bootstrap SE
Block Bootstrap p-value

(0.011)
{0.002}

(0.010)
{0.004}

(0.010)
{0.004}

(0.012)
{0.002}

(0.012)
{0.004}

(0.011)
{0.002}

Observations
R-squared
Year FE
Region FE
Disease FE
Region by Year FE
Region Trends

10,484
0.875
Yes
Yes
Yes
Yes
Yes

10,414
0.901
Yes
Yes
Yes
Yes
Yes

10,414
0.899
Yes
Yes
Yes
Yes
Yes

10,484
0.873
Yes
Yes
Yes
Yes
Yes

9,460
0.873
Yes
Yes
Yes
Yes
Yes

9,408
0.899
Yes
Yes
Yes
Yes
Yes

Sensitive*Post

Note: The table presents coefficient estimates for the regressions of cause-specific mortality per 1,000 on
an indicator variable for disease specific penicillin-sensitivity after year 1947 in comparison to the pre-1947
regional mortality (columns 1-2), and in regions with high and low WWII destruction above the median
(columns 3-4). High and low cutoffs are determined respectively by being above and below the median of
the given sub sample mortality. Columns 5 and 6 present coefficient estimates for the regressions of annual
change of cause-specific mortality per 1,000 on the region-cause specific mortality at a baseline year, based
on the first sub-period (1924‚Äì1946) and for the second sub-period (1947‚Äì1955), respectively. The baseline
year is 1924 for the first sub-period, while it is 1947 for the second sub-period. The values in parentheses
represent robust standard errors (SE). We test the statistical significance of the difference between the
coefficient estimates from columns (1) vs. (2), (3) vs. (4), and (5) vs. (6) by pooling the samples from the
corresponding models and looking at the significance level of the estimate of a triple interaction term, that we
construct using the indicator variables for disease specific penicillin-sensitivity, post-47 level of mortality, and
the corresponding characteristic [e.g., for columns (1) and (2), the interaction term using the pooled sample
is Sensitive*Post*(High Penicillin-Sensitive Mortality)]. Cause-specific mortality per 1,000 is in levels. All
columns include year, region, disease fixed effects, region-specific trends, and an interpolated population
estimate for age bins 0‚Äì25, 26‚Äì30, 31‚Äì35, 36‚Äì40, 41‚Äì45, 46‚Äì50, 51‚Äì55, 56‚Äì60, 61‚Äì65, 66‚Äì70, 71‚Äì75, 76+.
Standard errors in parentheses are clustered by region. Block bootstrap p-values are indicated in curly
brackets.

34

Table 4 Regression results for Œ≤-convergence by high vs. low penicillin-sensitive mortality
Pre Penicillin Period (1924‚Äì1946)
Post Penicillin Period (1947‚Äì1955)
Sample
High PenicillinLow PenicillinHigh PenicillinLow PenicillinSensitive
Sensitive
Sensitive
Sensitive Mortality
Mortality
Mortality
Mortality
(1)
(2)
(3)
(4)
Baseline
mortality (1924
or 1947)

Observations
R-squared
Region FE

-0.021***

-0.002

-0.075***

0.009***

(0.001)

(0.002)

(0.002)

(0.002)

162
0.913
Yes

424
0.059
Yes

161
0.936
Yes

508
0.149
Yes

Note:The table presents coefficient estimates for the regressions of annual change of cause-specific mortality
per 1,000 on the region-cause specific mortality at a baseline year. Columns 1 and 2 show results for the first
sub-period (1924‚Äì1946), and columns 3 and 4 for the second sub-period (1947‚Äì1955). The baseline year is
1924 for the first sub-period, while it is 1947 for the second sub-period. The values in parentheses represent
robust standard errors.

35

Table 5 Effect of Penicillin on the Standard Deviation of Mortality Rates and Level of Mortality for Penicillin-Sensitive and -Insensitive Diseases
Outcome
Standard Deviation (Sigma-convergence)
Mortality Rate
Category
Sensitive
Insensitive
Sensitive
Insensitive
(1)
(2)
(3)
(4)

36

Post (Full Sample ‚Äìend 1955)

-0.113***
(0.014)

-0.004
(0.009)

-0.600***
(0.075)

-0.340***
(0.095)

Post (Truncated Sample ‚Äìend 1950)

-0.090***
(0.014)

-0.009
(0.009)

-0.486***
(0.075)

-0.363***
(0.097)

-0.023

0.005

-0.114

0.023

Difference in Post Coefficients (1955-1950)

Note: OLS regressions collapsed across deaths within region-years on an indicator for post introduction of Penicillin, region fixed effects, population in
various age categories and linear time trends. The outcome in columns (1) and (2) is the standard deviation in mortality for sensitive and insensitive
diseases, respectively. The outcome in columns (3) and (4) is the level of mortality from sensitive and insensitive diseases, respectively. Each cell
in rows (1) and (2) reports the coefficient on the post indicator. The sample varies by row, extending over the entire analytical time period in row
(1) and truncating in 1950 in row (2). Row (3) reports the difference between the full and truncated sample values. If competing risks are driving
the results, the effects in row (2) should be considerably less negative in row (1), columns (2) and (4), due to individuals in the lowest part of the
health distribution surviving infectious disease due to the introduction of Penicillin but dying at higher rates a few years later from non-communicable
mortality.

Appendix A
A.1 - The data-set on Causes of Death in Italy (1924-1955)
In Italy data on mortality are collected routinely by the Italian National Statistical Office
(ISTAT) since 1888 and are published in the Health Statistics Yearbooks (Annuari di Statistiche Sanitarie). As disease classifications have changed over time, we can identify 5 time
intervals, based on 5 different classifications: 1888-1955, 1956-1957, 1958-1967, 1968-1969
and after 1969. For our study we focus on the 1888-1955 period, although for convenience
we use the classification adopted in 1956-1957 as our reference classification (it presents
the less disaggregated set of information: 17 main causes of death and 99 more specific
pathologies) and, therefore, we have re-organized the 1888-1955 classifications to reflect the
1956-1957 classification.
Originally, data for the period 1888-1955 were available only on paper in a single document printed by ISTAT (ISTAT, 1958) and presented in form of time series by region and
cause of death. For our purposes all tables have been scanned and saved in form of excel
files. These row data have been further processed and double-checked in order to avoid
errors from the scanning process. During the 1888-1955 period the classification follows the
International Analytical Classification (IAC) code, which was approved in 1948 (ICD, 1948)
and adopted in Italy from 1951. The reconstruction of the time series before year 1951 has
been carried out by ISTAT. The classification adopted in 1956 and 1957 has changed from
the IAC to the ISTAT Intermediate Classification (IIC) coding system. Table A.1 provides
a detailed list of all diseases with the relative IIC code, while Table A.2 provides a link
between the IIC and the IAC coding system.
The first column provides a brief description of the 17 main causes of death; the second
column reports the ISTAT classification used to identify causes (ranging from I to XVII)
and pathologies (ranging from 1 to 99); the third column describes the identification code
that we implemented starting from the ISTAT classification. It consists of 7 digits: the first
3 digits denote 1 out of the 17 causes of death (101 to 117); the following 2 digits denote 1
out of the 99 pathologies (from 01 to 99). The final 2 digits range from 00 to 10: they equal
zero for any of the 99 pathologies resulting from the 1956-1957 classification, and take on
different values (from 01 to 10) for further disaggregation of pathologies possibly occurred
either between years 1888-1955. In terms of regional disaggregation it is worth mentioning
that until 1923 data refers to the Italian partition of territories prior to the WWI; from 1924
to 1942, data are referred to the borders established after WWI; from 1943 onward, to the
borders after the WWII. Data prior to 1943 are referred, for each region, to the partition of
territories adopted at that time. Thus, the comparability across territories is imperfect for
those regions that have experienced border changes from 1927 (i.e., Veneto, Friuli-Venezia
Giulia, Umbria, Lazio, Abruzzi, Molise and Campania). To account for these geographical border changes and in order to have an harmonized regional disaggregation, we have
grouped together Abruzzi and Molise and Piedmont and Valle dAosta, that leads to have the
dataset disaggregated in the following 18 regions: Piedmont and Valle dAosta, Lombardy,
Trentino Alto Adige, Veneto, Friuli Venezia Giulia, Liguria, Emilia Romagna, Tuscany, Umbria, Marche, Lazio, Abruzzi and Molise, Campania, Apulia, Basilicata, Calabria, Sicily and
Sardinia.

37

A.2 - Construction of mortality rates
Mortality rates are obtained dividing number of deaths by resident population. Unfortunately, data on resident population by region is available only starting from 1922 and is
obtained through a reconstruction made by Golini, Ciucci, Caselli and ISTAT (1983). As
it is only from 1924 that Italy was organized in 18 administrative regions (with only minor
changes with small borderline municipalities changing regions after that date) we decided to
start our analysis starts in 1924. For all these reasons we limit our analysis from 1924 to 1955.

38

39

40

Appendix B

Tab. B1 - LIST OF PENNICILIN SENSITIVE CAUSE OF DEATH
FLAG
1 antib.
2 no antib.
3 uncertain
FLAG
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2

CODE
1010000
1010001
1010010
1010100
1010101
1010102
1010103
1010104
1010105
1010200
1010201
1010202
1010203
1010204
1010205
1010206
1010300
1010301
1010302
1010400
1010401
1010402
1011001
1011002
1011003
1011004
1011005
1011006
1064001
1064401
1064402
1064403
1064404
1064501
1074602
1074701
1075201
1085700
1085701
1085702
1085706
1085707
1085708
1085800
1085900
1085901
1086001
1086003
1086009
1096200
1096201
1096202
1097004
1107100
1107101
1107102
1107103
1107104
1107302
1107502
1107602
1107604
1117701
1117702
1117802
1128101
1128102
1138202
1138300
1158800
1010500
1010600
1010700
1010800
1010801
1010802
1010900
1011007
1020000
1020001
1020010
1021100
1021101
1021102
1021103
1021105
1021200
1021201
1021300
1021301
1021302
1021400
1021500
1021600
1021601
1021602
1021700
1021800
1021802
1021900
1021901
1022000
1022100
1022101
1022200
1022300
1022301
1022302
1022303
1022304
1022305
1022400
1022500
1022600
1022601
1022602

TOTAL DEATH BY 17 MAIN CAUSES

YEARS AVAILABLE
10
101,000
101,000
101,001
101,010
101,010
101,010
101,010
101,010
101,011
101,020
101,020
101,020
101,020
101,020
101,021
101,021
101,030
101,030
101,030
101,040
101,040
101,040
101,100
101,100
101,100
101,100
101,101
101,101
106,400
106,440
106,440
106,440
106,440
106,450
107,460
107,470
107,520
108,570
108,570
108,570
108,571
108,571
108,571
108,580
108,590
108,590
108,600
108,600
108,601
109,620
109,620
109,620
109,700
110,710
110,710
110,710
110,710
110,710
110,730
110,750
110,760
110,760
111,770
111,770
111,780
112,810
112,810
113,820
113,830
115,880

14
1010,000
1010,001
1010,010
1010,100
1010,101
1010,102
1010,103
1010,104
1010,105
1010,200
1010,201
1010,202
1010,203
1010,204
1010,205
1010,206
1010,300
1010,301
1010,302
1010,400
1010,401
1010,402
1011,001
1011,002
1011,003
1011,004
1011,005
1011,006
1064,001
1064,401
1064,402
1064,403
1064,404
1064,501
1074,602
1074,701
1075,201
1085,700
1085,701
1085,702
1085,706
1085,707
1085,708
1085,800
1085,900
1085,901
1086,001
1086,003
1086,009
1096,200
1096,201
1096,202
1097,004
1107,100
1107,101
1107,102
1107,103
1107,104
1107,302
1107,502
1107,602
1107,604
1117,701
1117,702
1117,802
1128,101
1128,102
1138,202
1138,300
1158,800

26
10100,000
10100,010
10100,100
10101,000
10101,010
10101,020
10101,030
10101,040
10101,050
10102,000
10102,010
10102,020
10102,030
10102,040
10102,050
10102,060
10103,000
10103,010
10103,020
10104,000
10104,010
10104,020
10110,010
10110,020
10110,030
10110,040
10110,050
10110,060
10640,010
10644,010
10644,020
10644,030
10644,040
10645,010
10746,020
10747,010
10752,010
10857,000
10857,010
10857,020
10857,060
10857,070
10857,080
10858,000
10859,000
10859,010
10860,010
10860,030
10860,090
10962,000
10962,010
10962,020
10970,040
11071,000
11071,010
11071,020
11071,030
11071,040
11073,020
11075,020
11076,020
11076,040
11177,010
11177,020
11178,020
11281,010
11281,020
11382,020
11383,000
11588,000

DESCRIPTION
infective and parasitic diseases (total)
infective and parasitic diseases (females)
infective and parasitic diseases (males)
tubercolosis of respiratory system
all forms of tubercolosis
pulmonary tubercolosis
pleural tubercolosis
adenopatia tubercolosis, tracheo-bronch. with symptoms
other tubercolosis of respiratory system
other types of tubercolosis (total)
tbc of meningis and central nervous system
intestinal tbc, peritoneal and mesenteric glands
tbc of the bones
tbc linfatic system
tbc genitourinary system
other types of tubercolosis (residual)
syphilis and consequences
syphilis of central nervous system
other types of syphilis and its consequences
typhoid and paratyphoid fevers
typhoid fevers
paratyphoid fevers
gonococcic infections
other venereal diseases
brucellosis
alimentary infections
scarlat fever
septicemia and piemia
meningithis
keratitis
inflammations of lacrimal glands and tear duct
other inflammatory eye diseases
corneal ulcer
mastoiditis and otitis media
acute articular rheumatism with cardiac complications
mitral valve diseases, rheumatic and non specified diseases
endocarditis, myocarditis, and acute and subacute pericarditis
pneumonia
acute tonsillitis
other acute infections of upper respiratory tract
lobar pneumonia
other pneumonias
acute infections of respiratory tract, influenza and pneumonia
bronchopneumonia
bronchitis
acute and subacute bronchitis and not-specified bronchitis
other diseases and infections of upper respiratory tract
tonsils abscess
lung abscess
appendicitis
acute appendicitis
other types of appendicitis
peritonitis
nephritis and nephrosis
acute nephritis
other nephritis or nephrosis
hydronephrosis and pyelorenal infections
pyelorenal infections
cistitis
orchitis and epididymitis
salpingitis and oophoritis
infective diseases of uterus, vagina, and vulva
infections of genito urinary system during pregnancy
pregnancy toxemia
abortion with infection
furunculus, anthrax and other abscesses
other skin and cellulat tissue infections
rheumatoid arthritis and similar diseases
osteomyelitis and periostitis
infections of newborns
difterite
pertosse
tetanus
acute anterior poliomyelitis and its postums
poliomyelitis
postums of acute anterior poliomyelitis
morbillus
parotite epidemica
tumors (total)
tumors (females)
tumors (males)
cancers of mouth and throat
all malignant tumors
cancers of lips
cancers of tongue
other cancers of mouth and throat
cancers stomach
cancers esophagus
intestinal cancers
intestinal cancers and duodenal cancers
rectal cancers
cancers biliary tract and liver
other cancers digestive system
laryngeal cancers, cancers of trachea, bronchial tubes, and lungs
laryngeal cancers
cancers of trachea, bronchial tubes, and lungs
other cancers of respiratory system
breast cancers
cancers of female genital organs
cervical uterus cancers
cancers of other parts of uterus
cancers of other female genital organs
prostate cancers
other cancers of male genital organs
cancers of urinal organs
cancers of other areas
hodgking disease
cancers of skin
cancers of brain and of other parts of nervous system
cancers of bones, cancers of connective and muscular tissue
other non-specified cancers
leukemia and aleukemia
others lymphoblastomas
all benign tumors
other benign tumors of non specific origins
benign tumors of breast

FROM
UNTIL
1887
1969
1958
1969
1958
1969
1956
1969
1887
1955
1958
1967
1958
1967
1958
1967
1958
1967
1956
1969
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1887
1969
1958
1967
1958
1967
1887
1969
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1887
1967
1959
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1887
1969
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1956
1969
1887
1969
1958
1967
1958
1967
1958
1967
1958
1967
1924
1969
1958
1967
1958
1967
1887
1967
1887
1969
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1956
1969
1956
1957
1887
1969
1887
1969
1887
1969
1899
1969
1958
1967
1958
1967
1887
1969
1958
1967
1887
1969
1958
1969
1958
1969
1956
1969
1887
1955
1958
1967
1958
1967
1958
1967
1956
1969
1958
1967
1956
1969
1958
1967
1958
1967
1956
1969
1956
1969
1956
1969
1958
1967
1958
1967
1956
1969
1956
1969
1958
1967
1956
1969
1958
1967
1956
1969
1956
1969
1958
1967
1956
1967
1956
1969
1942
1967
1958
1967
1958
1967
1958
1967
1958
1967
1931
1969
1956
1969
1931
1969
1958
1967
1958
1967

41

Tubercolosys
Syphilis and its consequences
Typhoid and paratyphoid fevers
Meningitis
Pneumonia
Bronchitis
Appendicitis
Peritonitis
Nephritis and nephrosis.

Tab. B1 - LIST OF PENNICILIN SENSITIVE CAUSE OF DEATH - Cntd
FLAG
1 antib.
2 no antib.
3 uncertain
FLAG
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2

CODE
1022603
1022604
1022605
1022606
1022607
1022608
1030000
1030001
1030010
1032700
1032701
1032702
1032800
1032801
1032802
1032803
1032804
1032900
1033000
1033001
1033100
1040000
1040001
1040010
1043200
1043201
1043202
1043203
1050000
1050001
1050010
1053400
1053401
1053402
1053403
1053404
1053405
1053406
1053407
1053500
1053501
1053502
1053503
1053504
1053505
1053600
1053601
1053602
1053603
1060000
1060001
1060010
1063700
1063800
1063900
1064000
1064002
1064100
1064200
1064201
1064202
1064300
1064301
1064302
1064303
1064405
1064406
1064407
1064408
1064409
1064500
1074600
1074601
1074700
1074702
1074800
1074900
1075000
1075100
1075200
1075202
1075203
1075300
1075301
1075302
1075400
1075401
1075402
1075500
1075600
1075601
1075602
1075603
1075604
1075605
1085703
1085704
1085705
1086002
1086005
1086006
1086010
1086011
1096100
1096102
1096104
1096105
1096106
1096107
1096108
1096109
1096110
1096300
1096301
1096302
1096400
1096500
1096600
1096602
1096700
1096800
1096801
1097002

TOTAL DEATH BY 17 MAIN CAUSES

YEARS AVAILABLE
10

14

26 DESCRIPTION
benign tumors of uterus
benign tumors of skin
benign tumors of bones and cartilages
lipomas
other not specific benign tumors
tumors of not specified origins
allergic diseases, endocrine gland disorders, metabolic and nutrition diseases (total)
allergic diseases, endocrine gland disorders, metabolic and nutrition diseases (females)
allergic diseases, endocrine gland disorders, metabolic and nutrition diseases (males)
allergic diseases
asthma
other allergic diseases
diseases of thyroid gland
goitre
thyrotoxicosis
other diseases of thyroid gland
diseases of thyroid and paratyroid glands
diabetes
diseases of other endocrine glands
diseases of other endocrine glands and other methabolism diseases
vitamine deficiency and other metabolic diseases
blood diseases and hematopoietic disorders (total)
blood diseases and hematopoietic disorders (females)
blood diseases and hematopoietic disorders (males)
anaemias
pernicious anaemia and other hyperchromic anaemias
hypocromic amaemias
other anaemias
psychic disorders, psychoneurosis and personality disorders (total)
psychic disorders, psychoneurosis and personality disorders (females)
psychic disorders, psychoneurosis and personality disorders (males)
psychosis
schizophrenia (premature dementia)
manic depressive psychosis
involutional melancholia
paranoia and paranoid psychosis
senile psychosis
alcoolic psychosis
other psychosis
psychoneurosis
anxiety states without somatic symptoms
hysterical reaction without anxiety state
neurodepressive reaction
psychoneurosis with somatic symptoms
other psychic disorders
psychic disorders of personality, intelligence, and behaviour
alchoolism
oligophrenia
other psychic disorders of personality, intelligence, and behaviour
nervous system diseases and sensory organs diseases (total)
nervous system diseases and sensory organs diseases (females)
nervous system diseases and sensory organs diseases (males)
hemorragia cerebral
cerebral thrombosis and embolism
vascular lesions of central nervous system
inflammatory diseases of central nervous system
other inflammatory diseases of central nervous system
epilepsia
other non-inflammatory diseases of central nervous system (total)
cerebral paralysis
other non-inflammatory diseases of central nervous system (residual)
diseases of peripheral nervous system
sciatica
other neuralgias and neuritis
other diseases of peripheral nervous system
strabismus
cataract
retina detachment
glaucoma
other non-inflammatory eye diseases
ear and mastoid apophysis diseases
acute articular rheumatism
acute articular rheumatism without cardiac complications
chronic rheumatic cardiopathies
other chronic rheumatic cardiopathies
heart atherosclerosis and coronary diseases
chronic non rheumatic endocarditis
degenerative myocardial atherosclerosis
other myocardial degenerations
other heart diseases
functional heart diseases
other heart diseases
hypertension with heart disease
benign hypertension with heart disease
other hypertensions with heart disease
hypertension without heart diseases
benign hypertension without heart disease
other hypertensions without heart disease
generalized atherosclerosis
other diseases of arteries and vascular peripheral
varicose veins lower limbs
hemorrhoids
other varicose veins with specified localizations
phlebitis and thrombophlebitis
other veins diseases and circulatory system diseases
influenza
influenza with bronchitis and bronchopneumonia
other types of influenza
tonsils hypertrophy and adenoids
nasal septum deviation
polyp nasal cavity
pneumoconiosis
bronchiectasia
gastric, duodenal and digiunal ulcer
teeth diseases
stomach and duodenal ulcers and other diseases of stomach and duodenum
stomach ulcer
duodenal ulcer
gastro-digiunal ulcer
gastritis, duodenitis and other diseases of stomach and duodenum
gastritis, duodenitis
other diseases of stomach and duodenum
abdominal hernia
abdominal hernia without mention of obstruction
abdominal hernia with obstruction
intestinal obstruction without mention of hernia
gastroenteritis, colitis, and non-ulcerative colitis 29th day to 3rd year
gastroenteritis from the 3rd year onwards and chronic colitis
gastroenteritis, colitis and ulcerative colitis
liver cirrhosis
biliary lithiasis and cholecystitis
bladder diseases and biliary tract diseases
functional disorders of intestine

42

FROM
UNTIL
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1933
1967
1887
1969
1958
1969
1958
1969
1924
1967
1958
1967
1958
1967
1956
1969
1958
1967
1958
1967
1958
1967
1887
1955
1887
1969
1956
1969
1887
1955
1956
1969
1887
1969
1958
1969
1958
1969
1956
1969
1924
1967
1958
1967
1924
1967
1887
1969
1958
1969
1958
1969
1956
1969
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1956
1969
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1956
1969
1958
1967
1958
1967
1958
1967
1887
1969
1958
1969
1958
1969
1956
1969
1956
1969
1887
1969
1956
1969
1958
1967
1887
1969
1956
1969
1931
1967
1958
1967
1956
1967
1958
1967
1958
1967
1958
1967
1963
1967
1958
1967
1958
1967
1958
1967
1958
1967
1956
1969
1956
1969
1958
1967
1956
1969
1958
1967
1956
1969
1956
1967
1956
1967
1956
1969
1956
1969
1958
1967
1958
1967
1956
1969
1958
1967
1958
1967
1956
1967
1958
1967
1958
1967
1956
1969
1956
1969
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1887
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1956
1969
1958
1967
1887
1955
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1956
1969
1958
1967
1887
1967
1956
1969
1956
1957
1956
1967
1887
1955
1887
1969
1956
1969
1931
1955
1958
1967

Note: This was not treated with antibiotics during this period

Note: This was not treated with antibiotics during this period
Note: This was not treated with antibiotics during this period

Tab. B1 - LIST OF PENNICILIN SENSITIVE CAUSE OF DEATH - Cntd
FLAG
1 antib.
2 no antib.
3 uncertain
FLAG
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3

CODE
1097003
1097006
1107200
1107400
1107501
1107605
1107606
1107608
1117703
1117704
1117801
1118001
1118002
1118003
1128103
1138200
1138201
1138203
1138204
1138205
1138401
1140000
1140001
1140010
1148500
1148600
1148601
1148602
1148603
1158700
1158900
1160000
1160001
1160010
1169200
1169300
1179702
1179800
1179900
1179901
1011000
1011008
1043300
1064400
1064502
1070000
1070001
1070010
1080000
1080001
1080010
1085902
1086000
1086004
1086007
1086008
1086012
1090000
1090001
1090010
1096101
1096103
1096900
1097000
1097001
1097005
1100000
1100001
1100010
1107105
1107300
1107301
1107303
1107500
1107503
1107600
1107601
1107603
1107607
1107609
1110000
1117700
1117705
1117800
1118000
1118004
1118005
1118006
1120000
1120001
1120010
1128104
1128105
1128106
1130000
1130001
1130010
1138400
1138402
1138403
1138404
1138405
1138406
1150000
1150001
1150010
1159000
1159100
1170000
1170001
1170010
1179400
1179500
1179501
1179600
1179602
1179603
1179604
1179700
1179703
1179704
1179705
1179706
1179707
1180000

TOTAL DEATH BY 17 MAIN CAUSES

YEARS AVAILABLE
10

14

26 DESCRIPTION
rhagades, anal and rectal abscess
cholecystitis without mention of calculus
calculus urinary system
prostatic hypertrophy and hyperplasia
hydrocele
genital prolapse
uterus deviations
menstrual disorders
placenta previa and hemorrhages in pregnancy
extra uterine pregnancy
abortion without infections, with or without toxemia
placenta previa and hemorrhage post-partum
dystocia due to anomaly of bone pelvis
dystocia due to anomaly of fetus
eczema
arthritis and rheumatism (except acute articular rheumatism
acute arthritis
arthrosis and similar diseases
other, not specified arthritis
rheumatism (except acute articular rheumatism)
osteitis deformans and osteochondrosis and other bone diseases
congenital malformations (total)
congenital malformations (females)
congenital malformations (males)
congenital malformations of circulatory system
other congenital malformations
congenital malformations of genitourinary system
congenital malformations of bones and articulations
remaining congenital malformations
obstetrical disorder, asphyxia and newborn infections
nutrition disorders
symptoms, senility, and pathological states (total)
symptoms, senility, and pathological states (females)
symptoms, senility, and pathological states (males)
senility without mention of psychosis
symptoms and causes mis-defined and unknown
accidental poisoning
suicides
homicides
suicides and homicides
other infectious and parasitic diseases
other infectious diseases
other blood diseases and hematopoietic organs
eyes diseases
other ear and mastoid apophysis diseases
circulatory system diseases (total)
circulatory system diseases (females)
circulatory system diseases (males)
respiratory system diseases (total)
respiratory system diseases (females)
respiratory system diseases (males)
chronic bronchitis
other diseases of respiratory tract
chronic sinusitis
remaining diseases and chronic infections of upper respiratory tract
pleurisy
remaining diseases of respiratory tract
digestive system diseases (total)
digestive system diseases (females)
digestive system diseases (males)
diseases mouth cavity and esophagus
other diseases mouth cavity and esophagus
other diseases of liver, pancreas
other diseases of digestive system
other diseases of intestine and peritoneum
remaining diseases of intestine and peritoneum
genitourinary system diseases (total)
genitourinary system diseases (females)
genitourinary system diseases (males)
hydronephrosis
other diseases of urinary system
other renal diseases and urethritis
remaining diseases of urinary system
other diseases of male genital organs
remaining diseases of male genital organs
breast diseases and disease of female genital organs
breast diseases
other diseases of female pelvic peritoneum
other uterus diseases
other disorders female genital organs
complications of pregnancy, childbirth, and the puerperium (total)
pregnancy complications
other complications in pregnancy
abortion
complications of childbirth, and the puerperium
other complications of childbirth
puerperium complications
breast-feeding disorders
skin and tissue diseases (total)
skin and tissue diseases (females)
skin and tissue diseases (males)
erythematosus affections
psoriasis and similar disorders
other skin and cellular tissue infections
bone diseases and locomotive organ diseases (total)
bone diseases and locomotive organ diseases (females)
bone diseases and locomotive organ diseases (males)
other diseases of bones locomotive organs
knee intra-articular disease
intervertebral disc diseases
other articular diseases
synovitis, bursitis and tenosynovitis
remaining diseases of osteo-muscolar system
early childhood particular diseases (total)
early childhood particular diseases (females)
early childhood particular diseases (males)
immaturity
other particular diseses of early childhood
accidents, traumatisms and poisonings (total)
accidents, traumatisms and poisonings (females)
accidents, traumatisms and poisonings (males)
accidents caused to pedestrian by motor vehicle
other accidents caused by motor vehicle
traffic accidents
accidents caused by other motor vehicles
accidents by transportation through waterways
aviation accidents
railway accidents
other accidents
accidental downfalls
accidents caused by fire-arms
accidental drowning
other accidents
trauma war
total deaths

43

FROM
UNTIL
1958
1967
1958
1967
1924
1969
1956
1969
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1956
1969
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1887
1969
1958
1969
1958
1969
1956
1969
1956
1969
1958
1967
1958
1967
1958
1967
1956
1969
1956
1969
1887
1969
1958
1969
1958
1969
1956
1969
1956
1969
1958
1967
1887
1969
1887
1969
1959
1967
1887
1969
1958
1967
1887
1969
1924
1969
1958
1967
1887
1969
1958
1969
1958
1969
1887
1969
1958
1969
1958
1969
1958
1967
1956
1969
1958
1967
1958
1967
1887
1967
1958
1967
1887
1969
1958
1969
1958
1969
1958
1967
1958
1967
1924
1969
1956
1969
1958
1967
1958
1967
1887
1969
1958
1969
1958
1969
1958
1967
1956
1969
1958
1967
1958
1967
1956
1969
1958
1967
1956
1969
1958
1967
1958
1967
1958
1967
1958
1967
1887
1969
1956
1969
1958
1967
1956
1969
1956
1969
1958
1967
1958
1967
1958
1967
1887
1969
1958
1969
1958
1969
1958
1967
1958
1967
1958
1967
1887
1969
1958
1969
1958
1969
1956
1969
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1887
1969
1958
1969
1958
1969
1956
1969
1956
1969
1887
1969
1958
1969
1958
1969
1956
1969
1956
1967
1958
1967
1956
1969
1958
1967
1958
1967
1958
1967
1887
1969
1958
1967
1958
1967
1958
1967
1958
1967
1958
1967
1887
1957

